Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of ATAI Life Sciences N.V (NASDAQ: ATAI) closed at $1.36 in the last session, down -7.48% from day before closing price of $1.47. In other words, the price has decreased by -$7.48 from its previous closing price. On the day, 1.23 million shares were traded. ATAI stock price reached its highest trading level at $1.445 during the session, while it also had its lowest trading level at $1.36.
Ratios:
We take a closer look at ATAI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.81 and its Current Ratio is at 5.81. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 18, 2024, Reiterated its Buy rating but revised its target price to $10 from $15 previously.
On April 03, 2024, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $6.
On November 01, 2022, Loop Capital started tracking the stock assigning a Buy rating and target price of $18.Loop Capital initiated its Buy rating on November 01, 2022, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 21 ’25 when Kirpekar Sahil sold 48,563 shares for $1.35 per share. The transaction valued at 65,560 led to the insider holds 115,636 shares of the business.
Craig Kevin James sold 11,563 shares of ATAI for $15,610 on Mar 21 ’25. The Chief Medical Officer now owns 8,437 shares after completing the transaction at $1.35 per share. On Mar 21 ’25, another insider, Rao Srinivas, who serves as the insider of the company, sold 75,418 shares for $1.35 each. As a result, the insider received 101,814 and left with 212,942 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATAI now has a Market Capitalization of 290442944 and an Enterprise Value of 234529776. For the stock, the TTM Price-to-Sale (P/S) ratio is 817.26 while its Price-to-Book (P/B) ratio in mrq is 1.57. Its current Enterprise Value per Revenue stands at 761.46 whereas that against EBITDA is -2.362.
Stock Price History:
The Beta on a monthly basis for ATAI is 1.20, which has changed by -0.27272725 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, ATAI has reached a high of $2.85, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is -20.30%, while the 200-Day Moving Average is calculated to be -5.32%.
Shares Statistics:
According to the various share statistics, ATAI traded on average about 2.87M shares per day over the past 3-months and 1748990 shares per day over the past 10 days. A total of 167.82M shares are outstanding, with a floating share count of 135.18M. Insiders hold about 31.83% of the company’s shares, while institutions hold 7.34% stake in the company. Shares short for ATAI as of 1741910400 were 10403773 with a Short Ratio of 3.63, compared to 1739491200 on 11160861. Therefore, it implies a Short% of Shares Outstanding of 10403773 and a Short% of Float of 6.5600000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
